US Stock MarketDetailed Quotes

Nautilus Biotechnology (NAUT)

Watchlist
  • 2.510
  • -0.110-4.20%
Close May 15 15:59 ET
  • 2.520
  • +0.010+0.40%
Post 20:01 ET
318.97MMarket Cap-5.46P/E (TTM)

Nautilus Biotechnology (NAUT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.01%-13.1M
14.29%-50.7M
13.52%-12.38M
15.85%-11.03M
13.63%-13.35M
14.32%-13.94M
-14.38%-59.15M
-2.94%-14.31M
-11.71%-13.11M
-14.08%-15.46M
Net income from continuing operations
11.53%-14.7M
16.64%-59M
21.67%-13.78M
17.46%-13.57M
16.53%-15.03M
11.30%-16.61M
-11.16%-70.78M
-3.35%-17.59M
-3.58%-16.45M
-13.93%-18.01M
Operating gains losses
----
----
----
----
----
----
--84K
----
----
----
Depreciation and amortization
-9.17%1.48M
0.43%6.47M
-2.99%1.59M
0.43%1.62M
2.25%1.63M
2.14%1.63M
12.83%6.44M
2.96%1.64M
8.70%1.61M
9.31%1.6M
Other non cash items
----
----
----
----
----
----
--760K
----
----
----
Change In working capital
-103.65%-1.17M
34.35%-3.58M
5.53%-1.52M
63.65%-269K
24.74%-1.22M
61.34%-576K
-69.59%-5.46M
-74.78%-1.61M
-513.41%-740K
-4.11%-1.62M
-Change in prepaid assets
-312.57%-355K
-18.32%544K
-42.92%395K
-124.44%-11K
-102.94%-7K
154.05%167K
181.12%666K
1,114.04%692K
149.45%45K
186.86%238K
-Change in payables and accrued expense
-16.75%328K
128.35%560K
42.11%-701K
268.80%922K
93.45%-55K
326.44%394K
-343.83%-1.98M
-4,006.45%-1.21M
-77.17%250K
-93.55%-840K
-Change in other current liabilities
-0.79%-1.15M
-12.96%-4.69M
-11.39%-1.21M
-14.01%-1.18M
-13.64%-1.16M
-12.91%-1.14M
-29.36%-4.15M
-8.04%-1.09M
-25.45%-1.04M
-20.02%-1.02M
Cash from discontinued investing activities
Operating cash flow
6.01%-13.1M
14.29%-50.7M
13.52%-12.38M
15.85%-11.03M
13.63%-13.35M
14.32%-13.94M
-14.38%-59.15M
-2.94%-14.31M
-11.71%-13.11M
-14.08%-15.46M
Investing cash flow
Cash flow from continuing investing activities
-27.05%14.23M
-46.83%35.22M
-97.88%787K
106.02%452K
1.26%14.47M
-12.71%19.51M
251.48%66.25M
190.37%37.11M
-157.38%-7.5M
733.88%14.29M
Net PPE purchase and sale
-132.88%-510K
39.82%-1.28M
3.94%-244K
41.04%-418K
22.66%-396K
66.15%-219K
13.10%-2.12M
38.50%-254K
18.88%-709K
-10.58%-512K
Net investment purchase and sale
-25.28%14.74M
-47.20%36.5M
-97.30%1.03M
112.81%870K
0.43%14.87M
-14.22%19.73M
267.42%69.13M
193.78%38.12M
-148.71%-6.79M
926.23%14.81M
Net other investing changes
----
----
----
----
----
----
---760K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-27.05%14.23M
-46.83%35.22M
-97.88%787K
106.02%452K
1.26%14.47M
-12.71%19.51M
251.48%66.25M
190.37%37.11M
-157.38%-7.5M
733.88%14.29M
Financing cash flow
Cash flow from continuing financing activities
6,038.89%1.11M
-81.29%214K
-77.05%101K
0
-70.22%95K
-92.65%18K
210.87%1.14M
73.91%440K
775.00%140K
225.51%319K
Proceeds from stock option exercised by employees
6,038.89%1.11M
-81.29%214K
-77.05%101K
--0
-70.22%95K
-92.65%18K
210.87%1.14M
73.91%440K
775.00%140K
225.51%319K
Cash from discontinued financing activities
Financing cash flow
6,038.89%1.11M
-81.29%214K
-77.05%101K
--0
-70.22%95K
-92.65%18K
210.87%1.14M
73.91%440K
775.00%140K
225.51%319K
Net cash flow
Beginning cash position
-53.26%13.39M
40.44%28.65M
359.75%24.88M
36.98%35.46M
28.09%34.24M
40.44%28.65M
-82.34%20.4M
-92.80%5.41M
-64.90%25.89M
-70.12%26.73M
Current changes in cash
-59.98%2.24M
-284.97%-15.26M
-149.43%-11.49M
48.32%-10.58M
244.43%1.22M
-11.69%5.59M
108.68%8.25M
142.48%23.24M
-1,613.38%-20.48M
94.63%-844K
End cash Position
-54.36%15.63M
-53.26%13.39M
-53.26%13.39M
359.75%24.88M
36.98%35.46M
28.09%34.24M
40.44%28.65M
40.44%28.65M
-92.80%5.41M
-64.90%25.89M
Free cash flow
3.86%-13.61M
15.17%-51.97M
13.35%-12.62M
17.15%-11.45M
13.92%-13.75M
16.30%-14.16M
-13.14%-61.27M
-1.75%-14.56M
-9.59%-13.82M
-13.97%-15.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.01%-13.1M14.29%-50.7M13.52%-12.38M15.85%-11.03M13.63%-13.35M14.32%-13.94M-14.38%-59.15M-2.94%-14.31M-11.71%-13.11M-14.08%-15.46M
Net income from continuing operations 11.53%-14.7M16.64%-59M21.67%-13.78M17.46%-13.57M16.53%-15.03M11.30%-16.61M-11.16%-70.78M-3.35%-17.59M-3.58%-16.45M-13.93%-18.01M
Operating gains losses --------------------------84K------------
Depreciation and amortization -9.17%1.48M0.43%6.47M-2.99%1.59M0.43%1.62M2.25%1.63M2.14%1.63M12.83%6.44M2.96%1.64M8.70%1.61M9.31%1.6M
Other non cash items --------------------------760K------------
Change In working capital -103.65%-1.17M34.35%-3.58M5.53%-1.52M63.65%-269K24.74%-1.22M61.34%-576K-69.59%-5.46M-74.78%-1.61M-513.41%-740K-4.11%-1.62M
-Change in prepaid assets -312.57%-355K-18.32%544K-42.92%395K-124.44%-11K-102.94%-7K154.05%167K181.12%666K1,114.04%692K149.45%45K186.86%238K
-Change in payables and accrued expense -16.75%328K128.35%560K42.11%-701K268.80%922K93.45%-55K326.44%394K-343.83%-1.98M-4,006.45%-1.21M-77.17%250K-93.55%-840K
-Change in other current liabilities -0.79%-1.15M-12.96%-4.69M-11.39%-1.21M-14.01%-1.18M-13.64%-1.16M-12.91%-1.14M-29.36%-4.15M-8.04%-1.09M-25.45%-1.04M-20.02%-1.02M
Cash from discontinued investing activities
Operating cash flow 6.01%-13.1M14.29%-50.7M13.52%-12.38M15.85%-11.03M13.63%-13.35M14.32%-13.94M-14.38%-59.15M-2.94%-14.31M-11.71%-13.11M-14.08%-15.46M
Investing cash flow
Cash flow from continuing investing activities -27.05%14.23M-46.83%35.22M-97.88%787K106.02%452K1.26%14.47M-12.71%19.51M251.48%66.25M190.37%37.11M-157.38%-7.5M733.88%14.29M
Net PPE purchase and sale -132.88%-510K39.82%-1.28M3.94%-244K41.04%-418K22.66%-396K66.15%-219K13.10%-2.12M38.50%-254K18.88%-709K-10.58%-512K
Net investment purchase and sale -25.28%14.74M-47.20%36.5M-97.30%1.03M112.81%870K0.43%14.87M-14.22%19.73M267.42%69.13M193.78%38.12M-148.71%-6.79M926.23%14.81M
Net other investing changes ---------------------------760K------------
Cash from discontinued investing activities
Investing cash flow -27.05%14.23M-46.83%35.22M-97.88%787K106.02%452K1.26%14.47M-12.71%19.51M251.48%66.25M190.37%37.11M-157.38%-7.5M733.88%14.29M
Financing cash flow
Cash flow from continuing financing activities 6,038.89%1.11M-81.29%214K-77.05%101K0-70.22%95K-92.65%18K210.87%1.14M73.91%440K775.00%140K225.51%319K
Proceeds from stock option exercised by employees 6,038.89%1.11M-81.29%214K-77.05%101K--0-70.22%95K-92.65%18K210.87%1.14M73.91%440K775.00%140K225.51%319K
Cash from discontinued financing activities
Financing cash flow 6,038.89%1.11M-81.29%214K-77.05%101K--0-70.22%95K-92.65%18K210.87%1.14M73.91%440K775.00%140K225.51%319K
Net cash flow
Beginning cash position -53.26%13.39M40.44%28.65M359.75%24.88M36.98%35.46M28.09%34.24M40.44%28.65M-82.34%20.4M-92.80%5.41M-64.90%25.89M-70.12%26.73M
Current changes in cash -59.98%2.24M-284.97%-15.26M-149.43%-11.49M48.32%-10.58M244.43%1.22M-11.69%5.59M108.68%8.25M142.48%23.24M-1,613.38%-20.48M94.63%-844K
End cash Position -54.36%15.63M-53.26%13.39M-53.26%13.39M359.75%24.88M36.98%35.46M28.09%34.24M40.44%28.65M40.44%28.65M-92.80%5.41M-64.90%25.89M
Free cash flow 3.86%-13.61M15.17%-51.97M13.35%-12.62M17.15%-11.45M13.92%-13.75M16.30%-14.16M-13.14%-61.27M-1.75%-14.56M-9.59%-13.82M-13.97%-15.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More